The Washington, DC National Photovoltaic Program (NPI), a leading scientific community that unites industry and academia with a focus on the Photonics Alliance today unveiled a white paper and cancer technology roadmap to identify the most promising private and public investment increases and common goals Achieve national cancer landings - accelerating early detection and saving of life's existing and new technologies. "A bright future: achieving cancer's goal of landing on the moon through the introduction of new and enhanced technologies and transforming its health system," details promised by the scientific community, leading medical technology industry, more than 350 hospitals and patient interest groups The nation leverages more than $3 billion a year in private investment in cancer research for early detection of cancer technology. â€
"The treatment of cancer is not a one-off event - it will take public-private partnerships and coordinated investment will accelerate the prevention, diagnosis and treatment of diseases," said Tom Bell, who presided over the NPI Cancer Lunar Task Force who participated in Vice President Joe Biden today. The Cancer Month Summit in Washington, DC. Like too many Americans, the vice president’s fight is a personal cancer. The photonic community and our partners have stood in the health care, industry and academia for their admiration and support for his mission, bringing a decade. The value of the progress in five years."
NPI mobilizes thought leaders from leading academic institutions, patient organizations, hospitals and medical device industries including the Lung Cancer Alliance, the Cancer Prevention Foundation, Siemens, the Advanced Medical Technology Association (AdvaMed), the Alliance Medical Imaging Technology (Company), and the American Optical Society ( OSA), International Society for Optics and Photonics (SPIE), MD Anderson Cancer Center, Stanford University, Rush University Medical Center, University of Texas Health Science Center, University of Chicago, Rice University. In its white paper and cancer technology roadmap, the consortium recommends an expansion of clinical research funding over the next five years, using existing non-invasive, minimally invasive, imaging technologies and companion molecules to detect early detection of cancer, coordinating public and private investments to Expanding funds for the development of new non-invasive quantitative imaging methods that are necessary for early detection and guidance of treatment, resources to develop a network of information technology (information technology) medical infrastructure available to our healthcare providers and consumption By.
“The good news is that our country can make significant progress in the next five years by effectively utilizing existing technologies and leveraging new investments to stimulate the development of low-cost, accurate, early detection technologies and treatment options,†Bell said. Early and more effective interventions, as well as stratified monitoring, rather than unnecessary interventions, promise better outcomes for patients and savings in the healthcare service network. â€
Optics and photons play a key role in healthcare technology, both in improving our ability to observe and measure symptoms, and our ability to treat patients with minimally invasive, more cost-effective methods. Photon-based medical tools provide sensitivity, accuracy, speed and accuracy to enable fast, personalized diagnosis and effective treatment.
"Advanced optics and photonics as well as high-sensitivity molecular diagnostic testing are welcoming these next-generation tools, and healthcare, will be beneficial to the entire cancer patient management spectrum is essential technology," said Allen Willner, NPI Steering Committee Chairman. "NPI expects to continue to work with a wide range of stakeholders to define and utilize opportunities that will significantly impact and strive to achieve the goals of the National Cancer Month Plan."
Stachyose Oligosaccharides,Indigestible Oligosaccharides,High Quality Stachyose,Pure Natural Stachyose
Shandong Bailong Chuangyuan Bio-tech Co.,Ltd. Qingdao Branch , https://www.qdblcycn.com